Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells

Mobilizing endogenous neural stem cells (NSCs) in the adult brain is designed to enhance the brain's regenerative capacity after cerebral lesions, e.g., as a result of stroke. Cerebral ischemia elicits neuroinflammatory processes affecting NSCs in multiple ways, the precise mechanisms of which currently remain elusive. An inhibitory effect of minocycline on microglia activation, a hallmark of postischemic neuroinflammation, has already been demonstrated in clinical trials, showing minocycline to be safe and potentially effective in ischemic stroke. Here we investigate the direct effects of minocycline and of proinflammatory cytokines on the differentiation potential of NSCs in vitro and in vivo. Primary fetal rat NSCs were treated with minocycline plus a combination of the proinflammatory cytokines tumor necrosis factor‐α, interleukin 1β, and interleukin 6. The differentiation fate of NSCs was assessed immunocytochemically. To investigate the effects of minocycline and inflammation in vivo, minocycline or lipopolysaccharides were injected intraperitoneally into adult rats, with subsequent immunohistochemistry. Minocycline alone did not affect the differentiation potential of NSCs in vivo or in vitro. In contrast, proinflammatory cytokines accelerated the differentiation of NSCs, promoting an astrocytic fate while inhibiting neurogenesis in vitro and in vivo. It is interesting to note that minocycline counteracted this cytokine‐induced rapid astrocytic differentiation and restored the neurogenic and oligodendrogliogenic potential of NSCs. Data suggest that minocycline antagonizes the rapid glial differentiation induced by proinflammatory cytokines following cerebral ischemia but without having a direct effect on the differentiation potential of NSCs. Thus, minocycline constitutes a promising drug for stroke research, counteracting the detrimental effects of postischemic neuroinflammation in multiple ways. © 2015 Wiley Periodicals, Inc.

[1]  F. Liu,et al.  Propofol Protects Against Focal Cerebral Ischemia via Inhibition of Microglia-Mediated Proinflammatory Cytokines in a Rat Model of Experimental Stroke , 2013, PloS one.

[2]  M. Tansey,et al.  Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity , 2013, ASN neuro.

[3]  Hong Chen,et al.  Elevated histone acetylations in Müller cell contribute to inflammation: A novel inhibitory effect of minocycline , 2012, Glia.

[4]  Gregor Bieri,et al.  Neural Progenitor Cells Regulate Microglia Functions and Activity States , 2012, Nature Neuroscience.

[5]  O. Lindvall,et al.  Cross-talk between neural stem cells and immune cells: the key to better brain repair? , 2012, Nature Neuroscience.

[6]  M. Hoehn,et al.  Effects of minocycline on endogenous neural stem cells after experimental stroke , 2012, Neuroscience.

[7]  D. Lang,et al.  Neuronal and glial differentiation during lizard (Gallotia galloti) visual system ontogeny , 2012, The Journal of comparative neurology.

[8]  J. Vukovic,et al.  Microglia Modulate Hippocampal Neural Precursor Activity in Response to Exercise and Aging , 2012, The Journal of Neuroscience.

[9]  G. O’Keeffe,et al.  A role for interleukin-1β in determining the lineage fate of embryonic rat hippocampal neural precursor cells , 2012, Molecular and Cellular Neuroscience.

[10]  K. Khalili,et al.  Nuclear Factor Kappa B Signaling Initiates Early Differentiation of Neural Stem Cells , 2012, Stem cells.

[11]  O. Witte,et al.  Effects of rehabilitative training and anti-inflammatory treatment on functional recovery and cellular reorganization following stroke , 2012, Experimental Neurology.

[12]  J. García-Verdugo,et al.  Reversible neural stem cell niche dysfunction in a model of multiple sclerosis , 2011, Annals of neurology.

[13]  F. Bosetti,et al.  Effects of neuroinflammation on the regenerative capacity of brain stem cells , 2011, Journal of neurochemistry.

[14]  G. Fink,et al.  Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns , 2010, Experimental & Translational Stroke Medicine.

[15]  J. Switzer,et al.  Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study , 2010, Stroke.

[16]  M. Mattson,et al.  Clathrin assembly proteins AP180 and CALM in the embryonic rat brain , 2010, The Journal of comparative neurology.

[17]  R. A. Schmiedt,et al.  Unmyelinated auditory type I spiral ganglion neurons in congenic Ly5.1 mice , 2010, The Journal of comparative neurology.

[18]  Elena Cattaneo,et al.  Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.

[19]  G. Fink,et al.  Noninvasive Imaging of Endogenous Neural Stem Cell Mobilization In Vivo Using Positron Emission Tomography , 2010, The Journal of Neuroscience.

[20]  R. Maccioni,et al.  Neuroimmunomodulation in the Pathogenesis of Alzheimer’s Disease , 2010, Neuroimmunomodulation.

[21]  Y. Nolan,et al.  Tumour necrosis factor-α impairs neuronal differentiation but not proliferation of hippocampal neural precursor cells: Role of Hes1 , 2010, Molecular and Cellular Neuroscience.

[22]  M. Colado,et al.  A Study on the Mechanisms by Which Minocycline Protects Against MDMA (‘Ecstasy’)-Induced Neurotoxicity of 5-HT Cortical Neurons , 2010, Neurotoxicity Research.

[23]  T. Palmer,et al.  Immune Influence on Adult Neural Stem Cell Regulation and Function , 2009, Neuron.

[24]  Deric M. Park,et al.  Targeting neural precursors in the adult brain rescues injured dopamine neurons , 2009, Proceedings of the National Academy of Sciences.

[25]  R. Anadón,et al.  Neurochemical characterization of sea lamprey taste buds and afferent gustatory fibers: Presence of serotonin, calretinin, and CGRP immunoreactivity in taste bud bi‐ciliated cells of the earliest vertebrates , 2008, The Journal of comparative neurology.

[26]  W. Schäbitz,et al.  MINOCYCLINE TREATMENT IN ACUTE STROKE: AN OPEN-LABEL, EVALUATOR-BLINDED STUDY , 2007, Neurology.

[27]  J. Price,et al.  Effect of Inflammatory Cytokines on Major Histocompatibility Complex Expression and Differentiation of Human Neural Stem/Progenitor Cells , 2008, Stem cells.

[28]  B. Schaar,et al.  Intracarotid Injection of Fluorescence Activated Cell-Sorted CD49d-Positive Neural Stem Cells Improves Targeted Cell Delivery and Behavior After Stroke in a Mouse Stroke Model , 2008, Stroke.

[29]  T. Hökfelt,et al.  Aberrant agouti‐related protein system in the hypothalamus of the anx/anx mouse is associated with activation of microglia , 2008, The Journal of comparative neurology.

[30]  J. Koo,et al.  IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress , 2008, Proceedings of the National Academy of Sciences.

[31]  C. Kaltschmidt,et al.  Neural stem cells, inflammation and NF-κB: basic principle of maintenance and repair or origin of brain tumours? , 2007, Journal of cellular and molecular medicine.

[32]  Yaniv Ziv,et al.  Toll-like receptors modulate adult hippocampal neurogenesis , 2007, Nature Cell Biology.

[33]  Henrik Ahlenius,et al.  Tumor Necrosis Factor Receptor 1 Is a Negative Regulator of Progenitor Proliferation in Adult Hippocampal Neurogenesis , 2006, The Journal of Neuroscience.

[34]  Daniel J. Hoeppner,et al.  Notch signalling regulates stem cell numbers in vitro and in vivo , 2006, Nature.

[35]  P. Simpson,et al.  Localization of the mouse α1A‐adrenergic receptor (AR) in the brain: α1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors , 2006 .

[36]  Richard J. Miller,et al.  Chemokines Regulate the Migration of Neural Progenitors to Sites of Neuroinflammation , 2006, The Journal of Neuroscience.

[37]  Henrik Ahlenius,et al.  Persistent Production of Neurons from Adult Brain Stem Cells During Recovery after Stroke , 2006, Stem cells.

[38]  Yaniv Ziv,et al.  Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells , 2006, Molecular and Cellular Neuroscience.

[39]  P. Simpson,et al.  Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. , 2006, The Journal of comparative neurology.

[40]  G. Comi,et al.  Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism , 2005, Nature.

[41]  C. Power,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd Minocycline and Neurological Diseases Minocycline in Animal Models the Promise of Minocycline in Neurology , 2022 .

[42]  D. Hess,et al.  Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats , 2004, BMC neurology.

[43]  J. Steeves,et al.  Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[44]  M. E. Eichler,et al.  Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[46]  O. Lindvall,et al.  Inflammation is detrimental for neurogenesis in adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  O. Lindvall,et al.  Neuronal replacement from endogenous precursors in the adult brain after stroke , 2002, Nature Medicine.

[48]  Hirofumi Nakatomi,et al.  Regeneration of Hippocampal Pyramidal Neurons after Ischemic Brain Injury by Recruitment of Endogenous Neural Progenitors , 2002, Cell.

[49]  B. Fiebich,et al.  Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.

[50]  P. Chan,et al.  A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Michael Schroeter,et al.  Inflammation and glial responses in ischemic brain lesions , 1998, Progress in Neurobiology.

[53]  S. Ekholm,et al.  Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. , 1995, Stroke.

[54]  T. Kammer,et al.  Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease , 1994, Journal of the Neurological Sciences.

[55]  G. Kreutzberg,et al.  Cytotoxicity of microglia , 1992, Journal of Neuroimmunology.